1. "Survivorship Research"
Formats
  1. Journal Article (8900)
  2. Meeting Abstract (5192)
  3. Book Section (571)
  4. Review (357)
  5. Editorial (225)
  6. Research Letter (132)
  7. Conference Paper (104)
  8. Correspondence (91)
  9. Guidelines (85)
  10. Miscellaneous (76)
  11. Book Whole (30)
Groups
  1. Survivorship Research (15763)
  2. Department of Medicine (9202)
  3. Population Sciences Research Program (5670)
  4. Solid Tumor Oncology Division (5184)
  5. Surgery (5131)
  6. Epidemiology and Biostatistics (3598)

More Groups

People
  1. Clifford Hudis (905)
  2. Kenneth Offit (788)
  3. Michael Zelefsky (754)
  4. Sergio Giralt (684)
  5. Mark Robson (676)
  6. Joachim Yahalom (625)

More People

Years
  1. 2025 (231)
  2. 2024 (802)
  3. 2023 (892)
  4. 2022 (906)
  5. 2021 (922)
  6. 2020 (930)

More Years

Publications
  1. Journal of Clinical Oncology (1873)
  2. International Journal of Radiation Oncology, Biology, Physics (908)
  3. Blood (685)
  4. Annals of Surgical Oncology (599)
  5. Cancer Research (333)
  6. Cancer (331)

More Publications

Publishers
  1. Elsevier Inc. (2658)
  2. American Society of Clinical Oncology (2019)
  3. Springer (1542)
  4. Wiley Blackwell (806)
  5. Oxford University Press (787)
  6. American Society of Hematology (748)

More Publishers

Results (15763)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Meditation for anxiety in stressful situations (MASS): Vaccinating oncology patients for COVID-19
    Meeting Abstract

    O'Leary, J.; Caramore, A.; Baser, R.; Barton-Burke, M.; Fessele, K.
    Oncology Nursing Forum (2022)

    Fulltext@MSK | Save
  • Cognitive behavioral therapy for insomnia comorbid with cancer
    Meeting Abstract

    Spiguel, E.
    Oncology Nursing Forum (2022)

    Fulltext@MSK | Save
  • Home cardiac surveillance with artificial intelligence digital patient monitoring during treatment with pertuzumab, trastuzumab and hyaluronidase-ZZXF for HER2-positive breast cancer (HARRIET): Study design and rationale
    Meeting Abstract

    Yu, A. F.; Ferraro, E.; Liu, J. E.; Advani, P.; Herrmann, J.; Yang, A.; Fung, A.; Day, B. M.; Xia, B.; Chacon, M.; more...
    Journal of the American College of Cardiology (2022)

    Fulltext@MSK | Save
  • Checkpoint inhibition induced pruritus during cancer therapy is associated with skin IL-31 and CCL22 expression
    Meeting Abstract

    Wang, E.; Lyubchenko, T.; Goleva, E.; Kraehenbuehl, L.; Ketosugbo, K.; Moy, A.; Hellmann, M.; Kern, J.; Lacouture, M.; Leung, D.
    Journal of Allergy and Clinical Immunology (2022)

    Fulltext@MSK | Save
  • Mosunetuzumab monotherapy is an effective and well-tolerated treatment option for patients with relapsed/refractory follicular lymphoma who have received ≥ 2 prior lines of therapy: Pivotal results from a phase I/II study
    Meeting Abstract

    Budde, E.; Sehn, L. H.; Matasar, M.; Schuster, S. J.; Assouline, S.; Giri, P.; Kuruvilla, J.; Canales, M.; Dietrich, S.; Fay, K.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin and prednisone (pola-R-CHP) versus rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) therapy in patients with previously untreated diffuse large B-cell lymphoma: Results from the phase III POLARIX study
    Meeting Abstract

    Tilly, H.; Morschhauser, F.; Sehn, L. H.; Friedberg, J. W.; Trněný, M.; Sharman, J. P.; Herbaux, C.; Burke, J. M.; Matasar, M.; Rai, S.; more...
    British Journal of Haematology (2022)

    Fulltext@MSK | Save
  • Who are we missing: Does engagement in patient reported outcome measures (PROM) for breast cancer vary by age, race, and disease stage?
    Meeting Abstract

    Srour, M. K.; Tadros, A.; Sevilimedu, V.; Nelson, J.; Cracchiolo, J.; McCready, T.; Silva, N.; Moo, T. A.; Morrow, M.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Hepatic arterial infusion pump chemotherapy for management of unresectable colorectal liver metastases with extrahepatic disease
    Meeting Abstract

    Saadat, L. V.; Goldman, D. A.; Gonen, M.; Soares, K. C.; Balachandran, V. P.; Wei, A. C.; Kingham, T. P.; Jarnagin, W. R.; Drebin, J.; Connell, L. C.; more...
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Association of moderate risk breast cancer genes with contralateral prophylactic mastectomy and bilateral disease
    Meeting Abstract

    Zhang, J.; dos Anjos, C.; Sevilimedu, V.; Crown, A.; Amoroso, K.; Zaman, U.; Pilewskie, M.; Gemignani, M. L.; Robson, M.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • How much pain will I have after surgery? A preoperative nomogram to predict moderate-severe pain following mastectomy
    Meeting Abstract

    Pak, L.; Pawloski, K.; Sevilimedu, V.; Kalvin, H.; Le, T.; Tokita, H.; Tadros, A.; Van Zee, K.; Kirstein, L.; Moo, T. A.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save